Yahoo Αναζήτηση Διαδυκτίου

Sign In

Αποτελέσματα Αναζήτησης

  1. www.ncbi.nlm.nih.gov › pmc › articlesAntibiotics for the treatment of COVID‐19 - PMC

    We found 11 studies with 11,281 people that investigated antibiotics to treat COVID‐19. All 11 studies investigated azithromycin. Nine studies (10,807 people) compared azithromycin to no treatment, placebo or usual care alone.

    • Figure 1

      Figure 1 - Antibiotics for the treatment of COVID‐19 - PMC

    • Analysis 1.2

      Analysis 1.2 - Antibiotics for the treatment of COVID‐19 -...

    • Table 4

      Table 4 - Antibiotics for the treatment of COVID‐19 - PMC

  2. www.ncbi.nlm.nih.gov › pmc › articlesTherapeutic drugs for SARS-CoV-2 treatment: Current state and ...

    27 Νοε 2020 · This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.

  3. www.ncbi.nlm.nih.gov › pmc › articlesCOVID-19 infection: Origin, transmission, and characteristics of...

    16 Μαρ 2020 · The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China and spread around the world.

  4. www.nature.com › articles › s41579/024/01036-yCOVID-19 drug discovery and treatment options - Nature

    15 Απρ 2024 · Originally developed for the treatment of HCV infection and Ebola virus disease, remdesivir also demonstrated antiviral activity against SARS-CoV and MERS-CoV in vivo 138,139.

  5. www.nature.com › articles › s41579/022/00713-0SARS-CoV-2 pathogenesis | Nature Reviews Microbiology

    30 Μαρ 2022 · Introduction. Coronaviruses (family Coronaviridae) are common pathogens of humans and animals. Four coronaviruses are endemic in humans (human coronavirus NL63 (HCoV-NL63), HCoV-229E,...

  6. www.nature.com › articles › s41551/020/00658-wDevelopment of vaccines and antivirals for combating viral ... -...

    8 Δεκ 2020 · Study participants recently diagnosed with SARS-CoV-2 infection received a single dose of 700, 2,800 or 7,000 mg of LY-CoV555 or placebo intravenously, and the change of viral load from...

  7. pubmed.ncbi.nlm.nih.gov › 33848886Antibiotics in treatment of COVID-19 complications: a review of...

    Patients' characteristics, clinical outcomes, as well as selected characteristics regarding antibiotic use (indication, class used, rates and types of bacterial secondary and co-infection, and duration of treatment) were analyzed. Results: Nineteen clinical studies reporting data from 2834 patients were included.